A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer V Jain, H Kumar, HV Anod, P Chand, NV Gupta, S Dey, SS Kesharwani Journal of Controlled Release 326, 628-647, 2020 | 195 | 2020 |
Multifunctional approaches utilizing polymeric micelles to circumvent multidrug resistant tumors SS Kesharwani, S Kaur, H Tummala, AT Sangamwar Colloids and Surfaces B: Biointerfaces 173, 581-590, 2019 | 71 | 2019 |
Molecular complexation of curcumin with pH sensitive cationic copolymer enhances the aqueous solubility, stability and bioavailability of curcumin S Kumar, SS Kesharwani, H Mathur, M Tyagi, GJ Bhat, H Tummala European Journal of Pharmaceutical Sciences 82, 86-96, 2016 | 66 | 2016 |
Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer Rakesh Dachineni , D. Ramesh Kumar Eduardo Callegari, Siddharth S ... International Journal of Oncology, 2017 | 62 | 2017 |
Hydrophobically modified inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intravenous route P Muley, S Kumar, F El Kourati, SS Kesharwani, H Tummala International journal of pharmaceutics 500 (1-2), 32-41, 2016 | 62 | 2016 |
Site-directed non-covalent polymer-drug complexes for inflammatory bowel disease (IBD): formulation development, characterization and pharmacological evaluation SS Kesharwani, R Ahmad, MA Bakkari, MKS Rajput, R Dachineni, ... Journal of Controlled Release 290, 165-179, 2018 | 58 | 2018 |
Dendritic cell-targeted nanovaccine delivery system prepared with an immune-active polymer MKS Rajput, SS Kesharwani, S Kumar, P Muley, S Narisetty, H Tummala ACS applied materials & interfaces 10 (33), 27589-27602, 2018 | 52 | 2018 |
The flavonoid metabolite 2, 4, 6-trihydroxybenzoic acid is a CDK inhibitor and an anti-proliferative agent: A potential role in cancer prevention R Sankaranarayanan, CK Valiveti, DR Kumar, SS Kesharwani, T Seefeldt, ... Cancers 11 (3), 427, 2019 | 48 | 2019 |
Overcoming multiple drug resistance in cancer using polymeric micelles SS Kesharwani, S Kaur, H Tummala, AT Sangamwar Expert opinion on drug delivery 15 (11), 1127-1142, 2018 | 47 | 2018 |
Pathogen-mimicking vaccine delivery system designed with a bioactive polymer (inulin acetate) for robust humoral and cellular immune responses Hemachand Tummala, Sunny Kumar, Siddharth S. Kesharwani, Bhimanna Kuppast ... Journal of Controlled Release, 2017 | 47 | 2017 |
Discovery of inulin acetate as a novel immune-active polymer and vaccine adjuvant: synthesis, material characterization, and biological evaluation as a toll-like receptor-4 agonist S Kumar, SS Kesharwani, B Kuppast, M Rajput, MA Bakkari, H Tummala Journal of Materials Chemistry B 4 (48), 7950-7960, 2016 | 39 | 2016 |
Design and evaluation of cabazitaxel loaded NLCs against breast cancer cell lines P Chand, H Kumar, N Badduri, NV Gupta, VG Bettada, ... Colloids and Surfaces B: Biointerfaces 199, 111535, 2021 | 34 | 2021 |
An overview of advanced formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of silymarin SS Kesharwani, V Jain, S Dey, S Sharma, P Mallya, VA Kumar Journal of Drug Delivery Science and Technology 60, 102021, 2020 | 30 | 2020 |
A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer H Kumar, NV Gupta, R Jain, SRV Madhunapantula, CS Babu, ... Journal of Advanced Research 54, 271-292, 2023 | 28 | 2023 |
Nobiletin as a Molecule for Formulation Development: An Overview of Advanced Formulation and Nanotechnology-Based Strategies of Nobiletin Siddharth S. Kesharwani, Pooja Mallya, Vadikari Arun Kumar, Vikas Jain ... AAPS PharmSciTech 21, 2020 | 26 | 2020 |
Hydrophobically modified inulin-based micelles: Transport mechanisms and drug delivery applications for breast cancer SS Kesharwani, R Dachineni, GJ Bhat, H Tummala Journal of Drug Delivery Science and Technology 54, 101254, 2019 | 21 | 2019 |
Characterization of differences in substrate specificity among CYP1A1, CYP1A2 and CYP1B1: an integrated approach employing molecular docking and molecular dynamics simulations SS Kesharwani, PP Nandekar, P Pragyan, V Rathod, AT Sangamwar Journal of Molecular Recognition 29 (8), 370-390, 2016 | 20 | 2016 |
Predicting drug metabolism by CYP1A1, CYP1A2, and CYP1B1: insights from MetaSite, molecular docking and quantum chemical calculations P Pragyan, SS Kesharwani, PP Nandekar, V Rathod, AT Sangamwar Molecular diversity 18 (4), 865-878, 2014 | 20 | 2014 |
Formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of zerumbone SS Kesharwani, GJ Bhat Medicina 56 (11), 557, 2020 | 15 | 2020 |
Comparative proteomics among cytochrome p450 family 1 for differential substrate specificity SS Kesharwani, PP Nandekar, P Pragyan, AT Sangamwar The Protein Journal 33 (6), 536-548, 2014 | 12 | 2014 |